Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Health And Human Services was posted on November 20, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Interventional Microbot System Development (TA2)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334510
New
Federal
NX EQ Transesophageal Echocardiography (TEE) Scanning Systems
Solicitation # 36C10X27R0011
The Department of Veterans Affairs is soliciting a single-award requirements contract for the procurement of Transesophageal Echocardiography (TEE) Scanning Systems to be used across various VA medical centers and facilities. This is a Brand Name or Equal solicitation based on the Philips Healthcare EPIQ CVx, requiring the delivery of new equipment and OEM parts, as remanufactured or refurbished items are prohibited. The contract includes a 12-month base period with four 12-month option periods, for a total potential duration of five years. The estimated quantity is 50 units for the base year and 50 units for each of the four option years. The scope of work encompasses the delivery of scanning systems, accessories, consumables, warranties, complete installation, and training for clinicians and biomedical engineers. This procurement is a total Service-Disabled Veteran-Owned Small Business (SDVOSB) set-aside, with a limitation that no more than 50 percent of the contract value be paid to non-SDVOSB or VOSB firms. Award will be based on best value, where non-price factors are significantly more important than price, and the technical factor is significantly more important than past performance. Technical evaluation focuses on imaging capabilities, data integration, and AI workflow optimizations, requiring a minimum rating of Acceptable for consideration. The contract mandates strict adherence to ADA and HIPAA requirements, and includes liquidated damages of $37.50 per calendar day for delays. All invoicing must be submitted electronically via the Tungsten/FSC e-Invoice program.
Sac Frederick (36C10X)

POSTED

about 11 hours ago

DEADLINE

in about 1 month
NAICS: 334510
New
DIBBS
DEFRIBRILLATOR, FULLY A
Solicitation # SPE2DS-27-T-1892
Solicitation SPE2DS-27-T-1892 is a small business set-aside procurement issued by the DLA Troop Support Medical Supply Chain for three fully automatic PowerHeart G5 defibrillators (NSN 6515-01-652-8530). Each unit must be a biphasic waveform system featuring voice prompts, an LED text screen, and dual-language capabilities in English and Latin American Spanish. Every complete kit must include a G5 fully automatic AED, an IntelliSense battery, a set of IntelliSense CPR feedback adult defibrillation pads, and a standard carry sleeve. Delivery is required within five days after receipt of order, with the destination point set as the USNS Mt Whitney LCC 20 at FPO AE 09517-3310. The contract mandates strict adherence to medical packaging and marking standards, specifically requiring Medical Marking Standard No. 1, which supersedes MIL-STD-129. All items must include Item Unique Identification (IUID) per MIL-STD-130 and DFARS 252.211-7003. The procurement is governed by fixed-price terms and simplified acquisition procedures, with invoicing and payment processed through the Wide Area WorkFlow (WAWF) system. Compliance with the Buy American Act, the Berry Amendment, and various cybersecurity and hazardous material regulations is required, including the prohibition of covered defense telecommunications equipment. Inspection and acceptance will occur at the destination.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 334510
New
Federal
Ultrasound Diagnostic System, Hand Carried (USHC) - Prototype
Solicitation # W91CRB-RPP-USHC
The Portfolio Acquisition Executive Maneuver Ground, Project Manager Maneuver Medical Systems is soliciting proposals for a Commercial-Off-The-Shelf or Non-Developmental Item hand-carried ultrasound diagnostic system to replace the end-of-life Sonosite M-Turbo. The required system must be FDA cleared for human use, Trade Agreements Act compliant, and capable of supporting medical operations in austere Role of Care 3 environments, specifically for FAST exams and ultrasound-guided procedures. This effort is being conducted under Other Transaction Authority pursuant to 10 U.S.C. 4022, meaning it is not a FAR-based procurement. A significant incentive is included, as a noncompetitive follow-on production contract may be awarded to the prototype participant. The selected vendor will deliver two prototype units within 45 to 60 days of award for operational and environmental testing conducted in accordance with MIL-STD-810H. The estimated period of performance is twelve months, with an anticipated award in the first quarter of FY27. Proposals are evaluated holistically based on technical approach, reliability, schedule realism, and past performance, with these non-cost factors carrying more weight than price. Submissions must be organized into four volumes covering the executive summary, technical approach, management/past performance, and cost, with a final response deadline of November 20, 2026.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

in 7 days

AI Contract Overview

Show more

The Interventional Microbot System Development (TA2) is a subcontract opportunity issued by the Advanced Research Projects Agency for Health under the Department of Health and Human Services. The project focuses on the design and development of microscale robots engineered for locomotion, sensing, and therapeutic application within primary care settings. A primary objective of the initiative is to ensure these systems feature safe targeting, actuation, and deactivation mechanisms suitable for clinical environments. The solicitation was posted on November 20, 2025, with a response deadline set for March 30, 2026. Classified under NAICS code 334510, the performance of this contract is centered in Washington, DC. This effort represents a specialized push toward integrating advanced robotics into healthcare for precise interventional treatments.

General Info

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Place of Performance

Washington, DC, 20071, USA

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SN-26-145.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Autonomous Interventions and Robotics (AIR) Advanced Research Projects Agency for Health (ARPA-H)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Design microscale robots capable of locomotion, sensing, and therapeutic action in primary care settings, with safe targeting, actuation, and deactivation in clinical contexts.

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541714
New
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 11 hours ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Solicitation # ARPA-H-SOL-26-163
The Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, issued by the Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office under solicitation ARPA-H-SOL-26-163, seeks innovative solutions to identify and act upon autism trajectories across the lifespan. The program focuses on the nonlinear interactions of genetic, biological, behavioral, and environmental factors to move toward personalized care. The scope is divided into four Technical Areas: TA1 focuses on multi-factor analysis and trajectory identification; TA2 involves population-scale modeling and data integration; TA3 centers on precision intervention and trajectory testing; and TA4 targets technologies for communication, quality of life, and embedded assessment. Awards will be made using Other Transaction (OT) instruments through a two-stage submission process consisting of a Solution Summary and a Full Proposal. Technical performance is monitored via a milestone-based system with evaluation gates at Month 10, Month 22, and a final evaluation at Month 46. Key requirements include strict adherence to HIPAA Privacy Rule de-identification standards, the implementation of independent data safety monitoring boards for harm surveillance, and the disclosure of any organizational conflicts of interest. Submissions must follow specific formatting guidelines, including the use of Avenir Next LT Pro font for summaries and a multi-volume structure for full proposals, with a response deadline of December 2, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 19 days
View Details
NAICS: 541714
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, seeks to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. This opportunity is open to researchers from academic, nonprofit, and industry organizations, provided the Principal Investigator is within eight years of completing their first terminal degree. The initiative covers 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. Awards are issued as Other Transaction (OT) agreements, which are not subject to the Federal Acquisition Regulation (FAR). The selection process is a two-step submission involving an initial anonymized Solution Summary and a subsequent Full Proposal for selected candidates. Successful awards have a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a 24-month base period capped at 700,000 dollars and an optional 12-month Director's Award period capped at 350,000 dollars. Payments are structured as fixed payments triggered by the completion of 12 discrete, measurable milestones. Full proposals are evaluated based on technical merit, innovativeness, feasibility, alignment with the ARPA-H mission to accelerate health outcomes, and price reasonableness. Administrative requirements include mandatory registration in SAM.gov and the use of the ARPA-H Solutions site for all submissions. Proposers must adhere to strict formatting templates for technical and management proposals, milestone schedules, and national policy requirements, including disclosures regarding organizational conflicts of interest and research security. Performance is monitored through a formal inspection and acceptance process where the government reviews deliverables within 14 calendar days. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

22 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the UNifying Imaging with QUantum Entanglement (UNIQUE) program, solicitation number ARPA-H-SOL-26-162. This 18-month, two-phase initiative aims to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data using quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: the Imaging Core, which focuses on physical systems for generating and measuring quantum observables, and the Computational Foundation, which focuses on AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction Agreements to eligible universities, non-profit organizations, and businesses. The submission process is two-staged, requiring Solution Summaries by late October 2026 and Full Proposals by December 15, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on technical innovation and feasibility, proposer expertise, potential to transform biomedicine, and cost reasonableness. Notably, for-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. All participants must adhere to strict HHS regulations regarding human stem cell research and prohibitions on dangerous gain-of-function research and funding for foreign entities in countries of concern.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 2 months ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS